JO
NNVC icon

John Overdeck’s NanoViricides NNVC Stock Holding History

John Overdeck’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,865
Closed -$22.8K – 3127
2023
Q2 		$22.8K Sell
19,865
-4,128
-17% -$4.99K ﹤0.01% 2896
2023
Q1 		$28.1K Sell
23,993
-3,700
-13% -$4.99K ﹤0.01% 2823
2022
Q4 		$30.7K Sell
27,693
-6,500
-19% -$10.1K ﹤0.01% 2646
2022
Q3 		$59K Buy
+34,193
New +$74.6K ﹤0.01% 2300

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

John Overdeck's NNVC Position: Q3 2023 in Review

John Overdeck sold out of NanoViricides (NNVC) in Q3 2023, closing a stake of 19,865 shares — an estimated $22.8K sold.

John Overdeck first reported a position in NNVC in Q3 2022 and held it in 4 quarters. The position peaked at $59K in Q3 2022. 30 funds tracked by Wall St. Rank hold NNVC as of Q3 2023.

  • John Overdeck reported no remaining NanoViricides position as of Q3 2023 after selling out during the quarter.
  • John Overdeck sold 19,865 NanoViricides shares in Q3 2023, an estimated $22.8K.
  • John Overdeck first reported a position in NanoViricides in Q3 2022 and held it in 4 quarters.
  • John Overdeck's NanoViricides position peaked at $59K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held NanoViricides as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.